Disclosures for "Pemigatinib For Previously Treated Central Nervous System Tumors With Activating FGFR Mutations or Translocations: Results From FIGHT-207")
-
The institution of Dr. Spanggaard has received research support from Roche. The institution of Dr. Spanggaard has received research support from Genentech. The institution of Dr. Spanggaard has received research support from Astra-Zeneca. The institution of Dr. Spanggaard has received research support from Incyte. The institution of Dr. Spanggaard has received research support from Pfizer. The institution of Dr. Spanggaard has received research support from MSD. The institution of Dr. Spanggaard has received research support from PUMA Biotechnology. The institution of Dr. Spanggaard has received research support from Orion Pharma.
-
Dr. Matrana has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AstraZeneca. Dr. Matrana has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for AstraZeneca . Dr. Matrana has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Seagen. Dr. Matrana has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Astellas . Dr. Matrana has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for BMS. Dr. Matrana has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Janssen. Dr. Matrana has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eisai . Dr. Matrana has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Exelixis . Dr. Matrana has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serano .
-
Dr. Rocha Lima has nothing to disclose.
-
Dr. Mahipal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca .
-
Ms. Vieito has nothing to disclose.
-
Alice Hervieu has nothing to disclose.
-
Myung-Ju Ahn has nothing to disclose.
-
Lipika Goyal has nothing to disclose.
-
Dr. Rodon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Peptomyc. Dr. Rodon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kelun Pharmaceuticals/Klus Pharma. Dr. Rodon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ellipses Pharma. Dr. Rodon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Molecular Partners. Dr. Rodon has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IONCTURA SA. The institution of Dr. Rodon has received research support from Blueprint Medicines. The institution of Dr. Rodon has received research support from Black Diamond Therapeutics . The institution of Dr. Rodon has received research support from Merck Sharp & Dohme. The institution of Dr. Rodon has received research support from Hummingbird. The institution of Dr. Rodon has received research support from Yingli. The institution of Dr. Rodon has received research support from Vall d'Hebron Institute of Oncology/Cancer Core Europe. The institution of Dr. Rodon has received research support from Novartis. The institution of Dr. Rodon has received research support from Spectrum Pharmaceuticals. The institution of Dr. Rodon has received research support from Symphogen. The institution of Dr. Rodon has received research support from BioAtla. The institution of Dr. Rodon has received research support from Pfizer. The institution of Dr. Rodon has received research support from GenMab. The institution of Dr. Rodon has received research support from CytomX. The institution of Dr. Rodon has received research support from Kelun-Biotech. The institution of Dr. Rodon has received research support from Takeda-Millenium. The institution of an immediate family member of Dr. Rodon has received research support from GlaxoSmithKline. The institution of Dr. Rodon has received research support from Taiho. The institution of Dr. Rodon has received research support from Roche Pharmaceuticals. The institution of Dr. Rodon has received research support from Bicycle Therapeutics. The institution of Dr. Rodon has received research support from Merus. The institution of Dr. Rodon has received research support from Curis. The institution of Dr. Rodon has received research support from Bayer. The institution of Dr. Rodon has received research support from AadiBioscience. The institution of Dr. Rodon has received research support from Nuvation. The institution of Dr. Rodon has received research support from ForeBio. The institution of Dr. Rodon has received research support from BioMed Valley Discoveries. The institution of Dr. Rodon has received research support from Loxo Oncology. The institution of Dr. Rodon has received research support from Hutchinson MediPharma. The institution of Dr. Rodon has received research support from Cellestia. The institution of Dr. Rodon has received research support from Deciphera. The institution of Dr. Rodon has received research support from Ideaya. The institution of Dr. Rodon has received research support from Amgen. The institution of Dr. Rodon has received research support from Tango Therapeutics. The institution of Dr. Rodon has received research support from Mirati. The institution of Dr. Rodon has received research support from Linnaeus Therapeutics . Dr. Rodon has received personal compensation in the range of $500-$4,999 for serving as a Member with European Society for Medical Oncology. Dr. Rodon has received personal compensation in the range of $500-$4,999 for serving as a Advisory Committee Member with Vall d'Hebron Institute of Oncology/Ministero De Empleo Y Seguridad Social. Dr. Rodon has received personal compensation in the range of $500-$4,999 for serving as a Advisory Committee Member with Chinese University of Hong Kong . Dr. Rodon has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Boxer Capital, LLC. Dr. Rodon has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Tang Advisors, LLC.
-
Dr. Veronese has received personal compensation for serving as an employee of Incyte. Dr. Veronese has stock in Incyte.
-
Mrs. Oliveira has received personal compensation for serving as an employee of Incyte. Mrs. Oliveira has stock in Incyte.
-
Dr. Li has nothing to disclose.
-
Dr. Schaffer has received personal compensation for serving as an employee of Incyte. Dr. Schaffer has stock in Incyte. Dr. Schaffer has stock in Johnson & Johnson.
-
Dr. Kesari has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for xcures. Dr. Kesari has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Duke.